Although Takeda Pharmaceuticals has known that side effects of Actos increase the risk of bladder cancer they introduced and sold the medication without warning consumers or the medical community. The FDA required new label information to be added to the drug, but the Actos warnings for bladder cancer remain inadequate…. Read more.
According to an order issued last week by the U.S. Judicial Panel on Multidistrict Litigation, the federal Actos litigation involving claims filed by individuals who developed bladder cancer after taking the popular diabetes drug will be centralized in the Western District of Louisiana for pretrial proceedings. It is expected that… Read more.
For the past several months, the Actos lawyers at Saiontz & Kirk, P.A. have been running television advertisements on a number of networks, including CMT, AMC, VH1, TV Land, TLC and other networks. These Actos TV commercials are designed to raise awareness about the link between bladder cancer and Actos,… Read more.
A large number of people with diabetes turned to Actos after concerns arose in 2007 about the potential risk of heart problems with Avandia, a rival medication used for treatment of type 2 diabetes. However, recent research suggests that Actos side effects may actually increase the risk of bladder cancer… Read more.
UPDATE 10/3/2011: Potential cases for prostate cancer from Actos are no longer being actively pursued or reviewed. The lawyers at Saiontz & Kirk, P.A. represent individuals throughout the United States who have been diagnosed with bladder cancer from Actos, a popular type 2 diabetes drug that the FDA has linked… Read more.
The Actos lawyers at Saiontz & Kirk, P.A. have been investigating and reviewing potential lawsuits for individuals throughout the United States who developed bladder cancer after using this popular diabetes drug. Although it appears that information has been available for some time about the connection between Actos and bladder cancer… Read more.
As evidence continues to mount that establishes a link between Actos and bladder cancer, the FDA is taking steps to make sure that consumers and the medical community are aware of the potential risk. However, it appears that Takeda Pharmaceuticals knew or should have known this information for years and… Read more.
France has suspended sales of Actos, a popular diabetes drug that has been linked to a possible risk of bladder cancer. The recall comes after a number of studies, leading some to question why an Actos recall has not been issued in the United States. >>MORE INFO: Actos and Bladder… Read more.
A recent study has detected an unusually high number of reports of bladder cancer that appear to be linked to the diabetes drug Actos. The lawyers at Saiontz & Kirk, P.A. are reviewing potential Actos lawsuits for individuals diagnosed with bladder cancer to determine whether financial compensation may be available… Read more.
